44 Wealth Management’s Medtronic MDT Stock Holding History

44 Wealth Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.96M	Buy	45,737 +26	+0.1%	+$2.49K	1.39%	9
2025 Q4	$4.39M	Buy	45,711 +148	+0.3%	+$14.4K	1.47%	6
2025 Q3	$4.34M	Sell	45,563 -5,044	-10%	-$464K	1.47%	5
2025 Q2	$4.41M	Buy	50,607 +3,102	+7%	+$263K	1.56%	5
2025 Q1	$4.27M	Buy	47,505 +353	+0.7%	+$31.6K	1.6%	6
2024 Q4	$3.77M	Sell	47,152 -2,886	-6%	-$250K	1.45%	6
2024 Q3	$4.62M	Buy	+50,038	New	+$4.21M	1.62%	5
2023 Q2	$4.09M	Buy	46,406 +23,860	+106%	+$2.05M	1.4%	16
2023 Q1	$1.82M	Buy	22,546 +512	+2%	+$41.7K	0.62%	43
2022 Q4	$1.71M	Buy	22,034 +4,345	+25%	+$352K	0.59%	47
2022 Q3	$1.43M	Buy	17,689 +5,241	+42%	+$471K	0.59%	49
2022 Q2	$1.12M	Buy	+12,448	New	+$1.26M	0.43%	65
2022 Q1	–	Sell	-6,748	Closed	-$698K	–	180
2021 Q4	$698K	Sell	6,748 -86	-1%	-$9.96K	0.24%	90
2021 Q3	$857K	Sell	6,834 -68	-1%	-$8.8K	0.33%	76
2021 Q2	$857K	Sell	6,902 -542	-7%	-$68.1K	0.33%	75
2021 Q1	$879K	Sell	7,444 -4,624	-38%	-$542K	0.37%	66
2020 Q4	$1.41M	Buy	+12,068	New	+$1.33M	0.64%	37

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

44 Wealth Management's MDT Position: Q1 2026 in Review

44 Wealth Management increased its Medtronic (MDT) stake by 0.06% in Q1 2026, buying an estimated $2.49K and bringing the position to 45,737 shares worth $3.96M. The position accounts for 1.39% of the portfolio, ranked #9.

44 Wealth Management first reported a position in MDT in Q4 2020 and has held it in 17 quarters since. The position peaked at $4.62M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

44 Wealth Management held 45,737 shares of Medtronic worth $3.96M as of Q1 2026.
44 Wealth Management bought 26 Medtronic shares in Q1 2026, an estimated $2.49K.
Medtronic made up 1.39% of 44 Wealth Management's portfolio in Q1 2026, its #9 holding.
44 Wealth Management first reported a position in Medtronic in Q4 2020 and has held it in 17 quarters since.
44 Wealth Management's Medtronic position peaked at $4.62M in Q3 2024.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on 44 Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.